Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Sponsored Content

Pin to quick picksUK Oil & Gas Regulatory News (UKOG)

Share Price Information for UK Oil & Gas (UKOG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.039
Bid: 0.038
Ask: 0.04
Change: 0.0025 (6.85%)
Spread: 0.002 (5.263%)
Open: 0.0365
High: 0.039
Low: 0.0365
Prev. Close: 0.0365

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

£3 million funding facility

28 Jun 2023 07:00

RNS Number : 1120E
UK Oil & Gas PLC
28 June 2023
 

UK Oil & Gas PLC

("UKOG" or the "Company")

 

 

£3 million funding facility

 

UK Oil & Gas PLC (London AIM: UKOG) is pleased to announce that it has secured a £3 million committed funding facility ("Loan") with RiverFort Global Opportunities PCC Ltd and YA II PN Ltd ("Investors").

 

The funds will fully fund working capital necessary to progress the Company's key planned activities over the next 12 months, which include:

 

· Turkey: further testing of Pinarova-1 and further drilling preparations/studies

· Loxley gas discovery: discharge of planning conditions and preparations for site construction, plus a potential farmout to cover the planned appraisal and development programme, 

· Horse Hill field: water reinjection work-over, preparations for 3D seismic acquisition and drilling Horse Hill-3 under the previously announced farmout to Pennpetro

· Portland hydrogen storage (UKEn): Planning application work and conceptual engineering studies.

 

Facility Summary:

 

· 3 committed tranches: £2 million receivable no later than 2 days after completion ("First Tranche"), £0.5 million receivable by no later than November 17th 2023, and £0.5 million receivable no later than February 16th 2024,

· Further advance of up to £2 million by mutual consent,

· 0% interest, repayable 18 months after each advance,

· Company retains a right to repay any outstanding amount of the Loan prior to the expiry of the term, subject to a repayment fee of 10% of the outstanding balance,

· Company can raise cash via equity as it may see fit during the Loan's term.

 

Loan discharge terms:

 

As part of the package the Company will issue to the Investors ordinary shares ("Equity Shares"), which represent between approximately 37% and 51% of the value of the First Tranche, or 1.3 billion new ordinary shares, dependent on whether the shares are valued at the Variable Price or Fixed Price, definitions of which are stated below. The Loan may, at the sole discretion of the Investors, be repaid by first applying the Equity Shares or, provided all Equity Shares have been applied, by converting the Loan into new ordinary shares in the Company. The price at which the Loan may be discharged either by applying the Equity Shares or converting the Loan is the lower of:

 

· the Variable Price, being equivalent to 100% (i.e., zero discount) of the Company's lowest daily volume weighted average price ("VWAP") in the 15 trading days preceding the conversion date or the date the Equity Shares are applied to discharge the Loan; or

· the Fixed Price, being the lower of either a 35% premium to a Reference Price being the average of the 5 daily VWAPs prior to the date of the relevant Loan drawdown (i.e., 135% of the Reference Price) or the lowest price at which the Company has issued equity in a fundraising whilst the loan is outstanding.

 

Any Equity Shares unsold at the end of the loan term or on early repayment shall be sold by the Investors and the net proceeds repaid to the Company.

 

All Investor share transactions are subject to:

 

· an orderly market provision that provides that the maximum number of shares which can be traded by the Investors or any of their affiliates in any calendar month shall be such number of shares which is equal to twenty (20) per cent of the number of shares of the Company that have traded during the previous calendar month (as confirmed by the reports available by Bloomberg or their equivalent);

· neither the Investors nor any of their affiliates shall hold any net short position with respect to the equity of UKOG during the Loan term; and

· Investors will exercise any share voting rights in support of any resolutions proposed by the Company.

 

The principal amount of each Advance is deemed to have been established with an accrued premium of 4.5% on the relevant drawdown date (i.e., a fee of 4.5% is incurred on each drawdown which will be added to the principal sum to be repaid).

 

On each drawdown date the Investors will also be granted warrants to subscribe for ordinary shares. Each Investor will be granted such number of warrants as is equal to 33% (in aggregate) of the relevant advance divided by the applicable Reference Price for that advance. In respect of the First Tranche the Investors will be granted 1,125,895,598 warrants. The warrants are exercisable at a premium of 140% of the 5-day average VWAP prior to the relevant drawdown for a period of 36 months from the relevant date of grant.

 

As is customary, the Loan contains certain default provisions.

 

 

Stephen Sanderson UKOG's Chief Executive commented:

"The facility provides the company with working capital at competitive terms to fully fund its planned key UK and Turkey activities over the coming year. The discharge/conversion terms are attractive in that they will be either at zero discount to the lowest daily VWAP in the 15-days prior to conversion, or at a premium of 35% to the Reference Price of the relevant drawdown, whichever is lower. This is in contrast to the likely heavy discount to the Company's share price associated with a more traditional share placing in today's financial climate. We look forward to working with the Investors, both of whom UKOG has transacted with successfully in the past."

 

For further information, please contact:

UK Oil & Gas PLC

 

Stephen Sanderson / Allen D Howard

 

Tel: 01483 941493

WH Ireland Ltd (Nominated Adviser and Broker)

 

James Joyce / James Bavister/ Andrew de Andrade

 

Tel: 020 7220 1666

Communications

 

Brian Alexander

Tel: 01483 941493

 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon publication of this announcement, this information is now considered to be in the public domain.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOESEDFWWEDSEDM
Date   Source Headline
17th Sep 20247:00 amRNSBoard Appointment
9th Sep 20247:00 amRNSSolent Cluster Hydrogen Storage LOS
21st Aug 202412:11 pmRNSResult of General Meeting
21st Aug 20247:00 amRNSSecond Dorset hydrogen storage site
8th Aug 20247:00 amRNSResults of Retail Offer
5th Aug 20244:28 pmRNSNotice of GM
5th Aug 20242:11 pmRNSEmployee Benefit Trust Share Subscription
5th Aug 20248:39 amRNSRetail Offer
5th Aug 20247:00 amRNSPlacing and Retail Offer to fund hydrogen storage
2nd Aug 20247:00 amRNSRWE Letter of Support for UKEn Hydrogen Storage
29th Jul 202411:36 amRNSHolding(s) in Company
26th Jul 20247:00 amRNSHolding(s) in Company
25th Jul 20247:00 amRNSConvertible loan fully repaid
22nd Jul 20244:24 pmRNSHolding(s) in Company
18th Jul 20244:33 pmRNSHolding(s) in Company
15th Jul 20247:00 amRNSChange of Nominated Adviser and Broker
10th Jul 20247:00 amRNSPlacing and termination of convertible loan
28th Jun 202412:27 pmRNSUnaudited results for six-month ended 31 Mar 2024
28th Jun 20247:00 amRNSD&M Horndean Field Resource Report
27th Jun 20247:00 amRNSDorset Hydrogen Storage: SGN LOS
21st Jun 20241:15 pmRNSLoan Reduction Update
20th Jun 202410:20 amRNSHorse Hill Update
12th Jun 202412:49 pmRNSLoan Reduction Update
4th Jun 20247:00 amRNSLoan Reduction Update
29th May 202412:10 pmRNSResult of AGM
29th May 20247:00 amRNSHydrogen Storage Project update: Sumitomo LOS
17th May 20247:00 amRNSLoan Reduction Update
3rd May 20244:28 pmRNSNotice of Annual General Meeting
3rd May 20247:00 amRNSEmployee Benefit Trust Share Subscription
2nd May 20247:00 amRNSLoan Reduction Update
1st May 20247:00 amRNSLoxley Gas Project Update
19th Apr 202411:59 amRNSLoan Reduction via Equity Share Subscription
2nd Apr 20247:00 amRNSAnnual Report for the year ended 30 September 2023
27th Mar 20247:00 amRNSLoxley Gas Project Update
19th Mar 20245:00 pmRNSBroadford Bridge Planning Update
13th Mar 20249:29 amRNSLoan Reduction via Equity Share Subscription
5th Mar 20243:28 pmRNSResult of Reconvened General Meeting
1st Mar 20247:00 amRNSRevised Timetable for Capital Restructuring
23rd Feb 20241:01 pmRNSNotice of General Meeting Resumption
22nd Feb 20244:37 pmRNSEmployee Benefit Trust Share Subscription
16th Feb 20241:54 pmRNSGeneral Meeting Adjournment
2nd Feb 20242:08 pmRNSPinarova-1 Testing Operations Update
1st Feb 20241:53 pmRNSProposed Capital Reorganisation
23rd Jan 20243:48 pmRNSLoan Balance Reduction via Equity Share Issue
23rd Jan 20247:00 amRNSPinarova-1 Testing Operations Commence
12th Jan 20247:00 amRNSSuccessful Placing
11th Jan 20247:00 amRNSTurkey: Pinarova-1 Testing
10th Jan 202411:39 amRNSEquity Share Issue and Reduction in Loan Balance
9th Jan 20242:00 pmRNSCourt of Appeal Upholds Loxley Planning Consent
3rd Jan 20241:04 pmRNSTurkey: Pinarova-1 Operations Re-Commence

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Track Your Investments

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.